Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression

par Wang, Lei, Devarajan, Eswaran, He, Jin, Reddy, Sekhar P., Le Dai, Jia
Publié 2005

Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis

par Egas-Bejar, Daniela, Anderson, Pete M., Agarwal, Rishi, Corrales-Medina, Fernando, Devarajan, Eswaran, Huh, Winston W., Brown, Robert E, Subbiah, Vivek
Publié 2014

Adipose Tissue-Derived Stem Cells Differentiate into Carcinoma-Associated Fibroblast-Like Cells under the Influence of Tumor-Derived Factors

par Jotzu, Constantin, Alt, Eckhard, Welte, Gabriel, Li, Jie, Hennessy, Bryan T., Devarajan, Eswaran, Krishnappa, Srinivasalu, Pinilla, Severin, Droll, Lilly, Song, Yao-Hua
Publié dans Anal Cell Pathol (Amst) (2010)

BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation

par Lewis, Valerae O., Devarajan, Eswaran, Cardó-Vila, Marina, Thomas, Dafydd G., Kleinerman, Eugenie S., Marchiò, Serena, Sidman, Richard L., Pasqualini, Renata, Arap, Wadih
Publié dans Proc Natl Acad Sci U S A (2017)

Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine

par Subbiah, Vivek, Wagner, Michael J., McGuire, Mary F., Sarwari, Nawid M., Devarajan, Eswaran, Lewis, Valerae O., Westin, Shanon, Kato, Shumei, Brown, Robert E., Anderson, Pete
Publié dans Oncotarget (2015)